leisure time -WSS

leisure time

author：explore 2025-09-28 02:47:24 - browse：23

A page of braille. -- health tech coverage from STAT — Adobe

Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well before the era of insulin pumps or even reliable home testing. The condition started eating away at her vision 20 years later. By the time she was 36, her sight was completely gone.

Keim had lived an independent life as a child despite her illness. Her summers were spent exploring oceans with her family, not at diabetic summer camps. Blindness, though, changed every aspect of her life — including her ability to manage her diabetes. Her first insulin pump had tactile buttons, but all the pumps that came to replace it had digital screens.

“Blind people cannot independently and safely manage our lives through the technology that’s available in home medical devices,” Keim said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Sutter Health’s antitrust win overturned by appeals court

WSS

BD to buy Edwards patient monitoring unit for $4.2 billion

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Newly revealed memo details efforts to keep Trump in power following election loss

A new initiative will help leaders fight the next pandemic

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Congress needs to close a vaccine

Wikipedia

leisure time

hotspot

Peter Hotez and the public health issue of online harassment

An outdated Medicare rule harms dementia patients with anxiety

Moonlake's readout produced a cash windfall. Risks remain

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Novavax promises a turnaround & Lilly roils the obesity market

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

ChatGPT in medicine: STAT answers readers' burning questions

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Duchenne breakthrough therapy leaves behind pioneering families

Eli Lilly’s Zepbound improved liver scarring in mid

entertainment

CMS got Medicare Advantage quality rating wrong, judge rules

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Target recalls 2.2 million additional candles due to laceration, burn hazards

ASCO Daily Recap: CAR

Illumina board agrees to spin off Grail, as divestment plans proceed

Elevance PBM president out as customers face prescription chaos

entertainment

hotspot

explore

hotspot